Needle-Free Influenza Vaccines: HKUMed Advances New Live-Attenuated Platforms with Cross-Subtype Potential Medical Countermeasures May 9, 2025 …
A Shot in the Dark? Vaccine Oversight in the Crosshairs of a Shifting U.S. Public Health Landscape Policy + Initiatives May 2, 2025 …
W.H.O. Partner Program Allocates 238,000 Doses of Mpox Vaccine to Four Countries Medical Countermeasures March 19, 2025 …
Tecovirimat Shown to Lack Efficacy as Treatment for Clade II Mpox Medical Countermeasures March 12, 2025 …
FDA Removes Clinical Hold on Novavax’s Combo COVID-Flu Vaccine Medical Countermeasures November 11, 2024 …
Lassa Fever Vaccine Study Supports Advancement to Phase I Trial Medical Countermeasures August 14, 2024 …
Soligenix Extends Patent Protection for Filovirus Vaccine Platform to UK and South Africa Industry News April 25, 2024 …
Study on Ebola Vaccines and Boosting Regimen Contributes to Future Outbreak Preparedness Medical Countermeasures April 3, 2024 …
Chikungunya Vaccine Candidate Granted Accelerated Review by EMA Medical Countermeasures February 23, 2024 …
Promising New ‘circRNA’ Vaccines Explored in CEPI-HMRI Collaboration Medical Countermeasures January 25, 2024 …
Novavax Updated Protein-Based COVID-19 Vaccine Authorized in the UK Medical Countermeasures January 24, 2024 …
